Search for: "Ryan v. Eli Lilly & Co." Results 1 - 7 of 7
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Mar 2020, 7:00 am by Andrew Hamm
Eli Lilly and Company 19-1061Issue: Whether, under Festo Corp. v. [read post]
11 Jan 2012, 2:02 pm
Eli Lilly & Co., 119 F.3d 1559, 1566 (Fed. [read post]
20 May 2012, 1:11 pm
 On the face of it, Plavix's patent expiry may have arguably paved the way for Eli Lilly & Co's and AstraZeneca's own blood-thinning drugs, Effient and Brilinta respectively, to gain more market share but the expiry of the patent does not mean that increasing the market share of their competitor drugs will be easy. [read post]